These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
987 related items for PubMed ID: 30253783
21. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis. Zhang XP, Wang K, Li N, Zhong CQ, Wei XB, Cheng YQ, Gao YZ, Wang H, Cheng SQ. BMC Cancer; 2017 Dec 28; 17(1):902. PubMed ID: 29282010 [Abstract] [Full Text] [Related]
22. Advanced radiotherapy technique in hepatocellular carcinoma with portal vein thrombosis: Feasibility and clinical outcomes. Khorprasert C, Thonglert K, Alisanant P, Amornwichet N. PLoS One; 2021 Dec 28; 16(9):e0257556. PubMed ID: 34555075 [Abstract] [Full Text] [Related]
23. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus. Ye JZ, Zhang YQ, Ye HH, Bai T, Ma L, Xiang BD, Li LQ. World J Gastroenterol; 2014 Dec 07; 20(45):17141-7. PubMed ID: 25493028 [Abstract] [Full Text] [Related]
27. Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis. Li S, Li L, Li B, Wang W. Br J Radiol; 2020 Aug 07; 93(1112):20190279. PubMed ID: 32464068 [Abstract] [Full Text] [Related]
29. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus. Zhang ZH, Liu QX, Zhang W, Ma JQ, Wang JH, Luo JJ, Liu LX, Yan ZP. World J Gastroenterol; 2017 Nov 21; 23(43):7735-7745. PubMed ID: 29209114 [Abstract] [Full Text] [Related]
33. Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis. Que J, Wu HC, Lin CH, Huang CI, Li LC, Ho CH. Medicine (Baltimore); 2020 Mar 21; 99(13):e19660. PubMed ID: 32221093 [Abstract] [Full Text] [Related]
37. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study. Fan W, Yuan G, Fan H, Li F, Wu Y, Zhao Y, Yao W, Wang Y, Xue M, Yang J, Li J. Clin Ther; 2019 Aug 21; 41(8):1463-1476. PubMed ID: 31303279 [Abstract] [Full Text] [Related]
38. Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma. Shen PC, Chang WC, Lo CH, Yang JF, Lee MS, Dai YH, Lin CS, Fan CY, Huang WY. Int J Radiat Oncol Biol Phys; 2019 Oct 01; 105(2):307-318. PubMed ID: 31175903 [Abstract] [Full Text] [Related]
39. Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis. Abdella H, Shaker MK, Montasser IF, Sobhi M, Aly H, Sayed A, Saleh S, El Dorry A. Indian J Gastroenterol; 2018 Mar 01; 37(2):127-132. PubMed ID: 29532323 [Abstract] [Full Text] [Related]
40. Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus. Pan T, Li XS, Xie QK, Wang JP, Li W, Wu PH, Zhao M. Clin Radiol; 2014 Dec 01; 69(12):e553-61. PubMed ID: 25304928 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]